Positive results from a study of ivacaftor (Kalydeco®) in children ages 1 to 2 were announced today.
Site Search
Showing 1 - 10 of 27 results
News
|
Dec. 7, 2017
|
2 min read
Two Phase 3 clinical trials of tezacaftor (VX-661) in combination with ivacaftor (Kalydeco®) showed positive results, Vertex Pharmaceuticals announced today.
News
|
March 28, 2017
|
4 min read
Galapagos and Cystic Fibrosis Foundation Therapeutics Sign €1.3 million* Agreement
Press Release
|
April 14, 2005
|
4 min read
Cystic Fibrosis Foundation Therapeutics to Provide Alnylam with $1.5 Million in Funding for Discovery Efforts
Press Release
|
March 16, 2005
|
5 min read
Press Release
|
Jan. 12, 2006
|
6 min read
Press Release
|
Feb. 14, 2006
|
3 min read
News
|
March 2, 2009
|
1 min read
Press Release
|
Jan. 23, 2008
|
6 min read
Press Release
|
July 8, 2008
|
5 min read
News
|
Aug. 1, 2008
|
1 min read